In Re Medicis Pharmaceutical Corp.
This text of In Re Medicis Pharmaceutical Corp. (In Re Medicis Pharmaceutical Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit
2009-1291 (Reexamination No. 90/008,068)
IN RE MEDICIS PHARMACEUTICAL CORPORATION
Frederick H. Colen, Reed Smith LLP, of Pittsburgh, Pennsylvania, argued for appellant. With him on the brief was Richard T. Ting.
Robert J. McManus, Associate Solicitor, Office of the Solicitor, United States Patent and Trademark Office, of Arlington, Virginia, argued for the Director of the United States Patent and Trademark Office. With him on the brief were Raymond T. Chen, Solicitor, and Janet A. Gongola, Associate Solicitor.
Appealed from: United States Patent and Trademark Office Board of Patent Appeals and Interferences NOTE: This disposition is nonprecedential.
Judgment ON APPEAL from the United States Patent and Trademark Office, Board of Patent Appeals and Interferences.
In CASE NO(S). 90/008,068.
This CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
Per Curiam (RADER, PLAGER, and PROST, Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
DATED December 14, 2009 /s/ Jan Horbaly Jan Horbaly, Clerk
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
In Re Medicis Pharmaceutical Corp., Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-medicis-pharmaceutical-corp-cafc-2009.